Eloxx Pharmaceuticals (NASDAQ: ELOX)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-08 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.120 | ||||||
REV | 2.330M | 0 | -2.330M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Eloxx Pharmaceuticals (NASDAQ: ELOX) through any online brokerage.
Other companies in Eloxx Pharmaceuticals’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and Akanda (NASDAQ:AKAN).
The latest price target for Eloxx Pharmaceuticals (NASDAQ: ELOX) was reported by Piper Sandler on Monday, May 23, 2022. The analyst firm set a price target for 1.50 expecting ELOX to rise to within 12 months (a possible 282.75% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Eloxx Pharmaceuticals (NASDAQ: ELOX) is $0.3919 last updated Today at August 17, 2022, 7:42 PM UTC.
There are no upcoming dividends for Eloxx Pharmaceuticals.
Eloxx Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Eloxx Pharmaceuticals.
Eloxx Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.